The Cigna Group which can be found using ticker (CI) have now 23 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 385 and 287 and has a mean target at $349.13. Now with the previous closing price of $265.29 and the analysts are correct then we can expect a percentage increase in value of 31.6%. The 50 day MA is $282.25 and the 200 day moving average is $294.56. The market cap for the company is $78,149m. Find out more information at: https://www.cigna.com
The potential market cap would be $102,847m based on the market consensus.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
The company has a dividend yield of 1.85% with the ex dividend date set at 7-3-2023 (DMY).
Other points of data to note are a P/E ratio of 12.35, revenue per share of 581.57 and a 3.34% return on assets.
